New Key Statistics Module, Z-Score and F-Score
OTCPK:TLTFF Key Ratios
| Market Cap $ M | 40.36 |
| Enterprise Value $ M | 38.06 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 7.83 |
| Price/Sales | 45.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.01 |
| Beneish M-Score | -2.74 |
| 10-y EBITDA Growth Rate % | 11.90 |
| 5-y EBITDA Growth Rate % | 9.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -13.61 |
| EV-to-EBITDA | -14.58 |
| PEG | -- |
| Shares Outstanding M | 310.48 |
| Net Margin (%) | -472.23 |
| Operating Margin % | -473.97 |
| Pre-tax Margin (%) | -472.23 |
| Quick Ratio | 5.11 |
| Current Ratio | 5.48 |
| ROA % (ttm) | -88.06 |
| ROE % (ttm) | -146.53 |
| ROIC % (ttm) | -216.89 |
| Dividend Yield % | -- |
| Altman Z-Score | 12.82 |
TLTFF Number of Guru Trades
TLTFF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TLTFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TLTFF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Theralase Technologies Inc Insider Transactions
No Available Data
News about OTCPK:TLTFF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers